A multivariate statistical analysis revealed that ALCAM-negative cases harbored a 1.876-fold higher risk of cancer recurrence (p = 0.022, 95% confidence interval 1.096–3.211) than ALCAM- positive cases, and ALCAM was an independent prognostic factor for TTR (Table 2). This evidence concerns the gene ALCAM and cancer.